Anti-obesity drug users experience a number of shifts in how they experience hunger and food, including 78% of whom report feeling full more quickly, and 64% who say they have fewer cravings for sweet foods, Schwan said, citing insights from a survey of more than 1,500 people actively taking GLP-1 medications that ADM conducted
Anyone experiencing symptoms of deficiency particularly neurological symptoms should seek medical review promptly rather than relying solely on self-supplementation
These movements supplement the compounds and address muscle groups that may not receive sufficient direct stimulus from the big lifts alone
Most current evidence is pre-clinical
That said, FLOW (Perkovic et al
Nonclinical studies in rodents of clinically relevant doses of GLP-1 receptor agonists showed dose-related and treatment-duration-dependent increases in the incidence of thyroid C-cell tumors (adenomas and carcinomas)